User's Manual
Table Of Contents
- System Operating Manual ®
- Table of Contents
- Section 1 Descriptive Information
- Section 2 Principles of Operation
- Section 3 Equipment Description
- Section 4 Basic Operation
- Section 5 Select Mode
- 5.1 Modes of Delivery
- 5.2 PCA Only Mode
- 5.3 Continuous Mode
- 5.4 PCA+Continuous Mode
- 5.5 Protocols
- 5.6 Dose Limit
- 5.7 Clearing the History and/or Rx Settings
- 5.8 Using Review/Confirmation Screens
- 5.9 Changing Settings During Setup
- 5.10 Making Changes After Setup
- 5.11 Clearing Shift Totals
- 5.12 Changing a Vial
- 5.13 Adding a Supplemental Loading Dose
- 5.14 Checking History & Settings
- 5.15 History and Event Log
- Section 6 Advanced Programming with Hospira MedNetTM Software
- Section 7 Troubleshooting
- Section 8 Maintenance
- Section 9 Specifications
- Section 10 Prescription Delivery Limits
- Appendix A Generating Bar Code Labels (Hospira MedNetTM Software Enabled)
- Appendix B Network Printer Setup
- Appendix C Warranty
- Appendix D Contact Information
- Index
LifeCare PCA Infusion System 1- 17
430-04685-001 (Rev. 7/05)
ALARMS
This section presents alarm information.
• If the MALFUNCTION Alarm Message is seen and sounds, press
the [ON/OFF] key to turn the infuser off. Then turn the infuser
back on. If the malfunction alarm repeats, remove the infuser from
service.
EPIDURAL ADMINISTRATION
This section contains epidural administration information.
• Recommended use of the epidural route is to provide anesthe-
sia or analgesia for periods up to 96 hours.
• It is strongly recommended that the epidural infusion system be
prominently identified as EPIDURAL. Failure to identify the infu-
sion system as epidural could result in incorrect administration
of intravenous rather than epidural formulations. In addition,
failure to identify the epidural infusion system could result in
confusion with other infusion systems delivering concomitant
intravenous formulations.
• This device can be used to administer only those anesthetics/
analgesics approved for epidural administration (as indicated or
allowed by the drugs’ FDA approved labeling). Epidural admin-
istration of drugs other than those indicated for epidural use
could result in serious injury to the patient.
• For epidural administration, the use of infuser sets without Y-
sites, and epidural stickers indicating ongoing epidural adminis-
tration are recommended.
• Administration of drugs via the epidural route should be limited
to personnel familiar with associated techniques and patient
management problems. Proper epidural placement of the cath-
eter is essential since catheter migration could result in intra-
vascular or intrathecal administration. Facilities practicing
epidural administration must be equipped with resuscitative
equipment, oxygen, naloxone, and other resuscitative drugs.
Adequate monitoring equipment is recommended for continu-
ous monitoring of the patient during epidural administration.
Patients must be observed frequently for side effects in a fully-
equipped and staffed environment for at least 24 hours follow-
ing completion of drug administration by the epidural route.